Usefulness of the Hybrid RFR-FFR Approach: Results of a Prospective and Multicenter Analysis of Diagnostic Agreement between RFR and FFR—The RECOPA (REsting Full-Cycle Ratio Comparation versus Fractional Flow Reserve (A Prospective Validation)) Study
Table 1
Baseline clinical characteristics.
Patients (n = 311)
Age (years), mean (SD)
65.4 (11.5)
Female gender, n (%)
61 (19.6%)
BMI (kg/m2), mean (SD)
28.2 (4.8)
Hypertension, n (%)
220 (70.7%)
Dyslipidemia, n (%)
221 (71.1%)
Diabetes mellitus, n (%)
No
200 (64.3%)
Non-insulin-dependent
88 (28.3%)
Insulin-dependent
23 (7.4%)
Smoking, n (%)
Not smoker
126 (40.5%)
Ex-smoker
118 (37.9%)
Current smoker
67 (21.5%)
Prior AMI, n (%)
82 (26.4%)
Prior stroke, n (%)
24 (7.7%)
Atrial fibrillation, n (%)
30 (9.6%)
Peripherical vasculopathy, n (%)
31 (10.0%)
COPD, n (%)
21 (6.8%)
Chronic kidney disease, n (%)
92 (30.6%)
Creatinine (mg/dL), mean (SD)
1.03 (0.61)
Glomerular filtration rate (mL/min/1.73 m2), mean (SD)
76.0 (31.1)
Clinical indication, n (%)
Stable ischemic heart disease
206 (66.2%)
NSTEACS culprit lesion
48 (15.4%)
NSTEACS nonculprit lesion
31 (10.0%)
STEACS nonculprit lesion
26 (8.4%)
SD, standard deviation; BMI, body mass index; AMI, acute myocardial infarction; COPD, chronic obstructive pulmonary disease; NSTEACS, non-ST segment elevation acute coronary syndrome; STEACS, ST segment elevation acute coronary syndrome.
